Investor Presentaiton slide image

Investor Presentaiton

Agenda 2 R&D investor presentation Introduction Once-weekly insulin Non-alcoholic steatohepatitis Cardiovascular disease Obesity Closing remarks Karsten Munk Knudsen, CFO Martin Lange, SVP, Global Development Martin Lange, SVP, Global Development Marcus Schindler, SVP, Global Drug Discovery Mads Krogsgaard Thomsen, CSO Karsten Munk Knudsen, CFO
View entire presentation